Physician

Wasim Samara, M.D.

According to 2025 Medicare claims, Wasim Samara, M.D. (NPI: 1275995177) practices ophthalmology in the Fayetteville, NC market, with the plurality of this provider's patient population coming from Cumberland, NC. This provider's primary affiliated billing organization is RETINA ASSOCIATES, PLLC (NPI: 1760408397; TIN: 562043271) and primary practice location at 28334-4864. Samara is affiliated with the Coastal Plains Network, LLC (ACO ID: A2684) and UT Southwestern Accountable Care Network (ACO ID: D0211), participating under both the MSSP and REACH models.

Samara's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 807 traditional Medicare patients, billed 15,524 HCPCS/CPT codes, and received $2,182,164 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 459 prescription claims across 138 beneficiaries totaling $14,297 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 26 records totaling $728. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $12,354 to $2,182,164. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $705 and ending at $14,297. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2020 Medicare payment: $12,354 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $36,472 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $546,150 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,356,566 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,182,164 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20207086$12,354
2021216288$36,472
20225202,899$546,150
202398515,454$2,356,566
202480715,524$2,182,164

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$26K2016 Drug cost: $705 (USD; Tot_Drug_Cst)2017 Drug cost: $8,743 (USD; Tot_Drug_Cst)2018 Drug cost: $3,727 (USD; Tot_Drug_Cst)2019 Drug cost: $26,097 (USD; Tot_Drug_Cst)2020 Drug cost: $2,206 (USD; Tot_Drug_Cst)2021 Drug cost: $2,269 (USD; Tot_Drug_Cst)2022 Drug cost: $6,054 (USD; Tot_Drug_Cst)2023 Drug cost: $16,922 (USD; Tot_Drug_Cst)2024 Drug cost: $14,297 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R21$705
20172886$8,743
201853101$3,727
2019176514$26,097
20203672$2,206
20214373$2,269
202254106$6,054
2023162460$16,922
2024138459$14,297

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2912,056$652
67028Injection of drug into eye4271,273$95
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more171191$68
92012Established patient problem focused exam of visual system374514$63
92134Imaging of retina7901,965$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1527,233$7,706
Ketorolac TromethamineKetorolac Tromethamine893,792$2,340
OfloxacinOfloxacin461,002$567
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat433,280$484
Timolol MaleateTimolol Maleate271,283$264

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.26$728Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wasim Samara, M.D.?

Tedicare shows public-source Medicare data for Wasim Samara, M.D. (NPI 1275995177), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wasim Samara, M.D. have ACO affiliation data?

Wasim Samara, M.D. is shown with ACO affiliation data for Coastal Plains Network, LLC (MSSP, ACO ID A2684) and UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Wasim Samara, M.D.?

Wasim Samara, M.D. is linked to RETINA ASSOCIATES, PLLC (billing NPI 1760408397) in the available physician profile data.

Does Wasim Samara, M.D. have Open Payments data?

Wasim Samara, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.